Your browser doesn't support javascript.
loading
SARS-CoV-2-induced disruption of a vascular bed in a microphysiological system caused by type-I interferon from bronchial organoids.
Fujimoto, Kazuya; Kameda, Yoshikazu; Nagano, Yuta; Deguchi, Sayaka; Yamamoto, Takuya; Krol, Rafal P; Gee, Peter; Matsumura, Yasufumi; Okamoto, Toru; Nagao, Miki; Takayama, Kazuo; Yokokawa, Ryuji.
Afiliação
  • Fujimoto K; Department of Micro Engineering, Kyoto University, Kyoto daigaku-Katsura, Nishikyo-ku, Kyoto 615-8540, Japan. yokokawa.ryuji.8c@kyoto-u.ac.jp.
  • Kameda Y; Department of Micro Engineering, Kyoto University, Kyoto daigaku-Katsura, Nishikyo-ku, Kyoto 615-8540, Japan. yokokawa.ryuji.8c@kyoto-u.ac.jp.
  • Nagano Y; Department of Micro Engineering, Kyoto University, Kyoto daigaku-Katsura, Nishikyo-ku, Kyoto 615-8540, Japan. yokokawa.ryuji.8c@kyoto-u.ac.jp.
  • Deguchi S; Center for iPS cell Research and Application (CiRA), Kyoto University, Shogoin-Kawahara-cho 53, Sakyo-ku, Kyoto, 606-8507, Japan. kazuo.takayama@cira.kyoto-u.ac.jp.
  • Yamamoto T; Center for iPS cell Research and Application (CiRA), Kyoto University, Shogoin-Kawahara-cho 53, Sakyo-ku, Kyoto, 606-8507, Japan. kazuo.takayama@cira.kyoto-u.ac.jp.
  • Krol RP; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
  • Gee P; Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Shogoin-Kawahara-cho 53, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Matsumura Y; Research and Development Center, CiRA Foundation, Shogoin-Kawahara-cho 53, Sakyo-ku, Kyoto, 606-8397, Japan.
  • Okamoto T; MaxCyte Inc., Gaithersburg, MD 20878, USA.
  • Nagao M; Department of Clinical Laboratory medicine, Kyoto University Graduate School of Medicine, Shogoin-Kawahara-cho 53, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Takayama K; Department of Microbiology, School of Medicine, Juntendo University, Hongo 2-1-1, Bunkyo-ku, Tokyo, 113-8421, Japan.
  • Yokokawa R; Department of Clinical Laboratory medicine, Kyoto University Graduate School of Medicine, Shogoin-Kawahara-cho 53, Sakyo-ku, Kyoto, 606-8507, Japan.
Lab Chip ; 24(16): 3863-3879, 2024 08 06.
Article em En | MEDLINE | ID: mdl-38252025
ABSTRACT
Blood vessels show various COVID-19-related conditions including thrombosis and cytokine propagation. Existing in vitro blood vessel models cannot represent the consequent changes in the vascular structure or determine the initial infection site, making it difficult to evaluate how epithelial and endothelial tissues are damaged. Here, we developed a microphysiological system (MPS) that co-culture the bronchial organoids and the vascular bed to analyze infection site and interactions. In this system, virus-infected organoids caused damage in vascular structure. However, vasculature was not damaged or infected when the virus was directly introduced to vascular bed. The knockout of interferon-related genes and inhibition of the JAK/STAT pathway reduced the vascular damage, indicating the protective effect of interferon response suppression. The results demonstrate selective infection of bronchial epithelial cells and vascular damage by cytokines and also indicate the applicability of MPS to investigate how the infection influences vascular structure and functions.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Brônquios / Interferon Tipo I / Organoides / SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Brônquios / Interferon Tipo I / Organoides / SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article